We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Study Suggests Language Delay Linked to Chromosome Deletion in Children with Neurological Disorders

By HospiMedica International staff writers
Posted on 25 Feb 2015
A study found that children with neuro-developmental problems born with DNA duplications or deletions on part of chromosome 16, show measurable delays in their ability to process sound and language. More...


Previous research had found changes in chromosome 16 correlated with some Autism Spectrum Disorders (ASDs), language impairments, and delays in developmental. The study was published online in the February 11th issue in the Cerebral Cortex journal.

The researchers studied 115 children. Forty-three of the children had DNA deletion, and 23 had DNA duplication. The control group consisted of 49 healthy children. Only a small number of the children had been diagnosed with ASD diagnoses.

The researchers used Magnetoncephalography (MEG), a functional neuroimaging technique, to detect magnetic fields in the brain. The children were exposed to a series of tones, and the MEG machine analyzed how magnetic fields in the child's brain changed. The researchers found a significant delay of 23 ms in children with the deletion, much higher than that experienced by the healthy children. The children with the duplication showed no such delay, and could process sounds slightly faster than the healthy children.

The study team included radiologists and psychologists, and was led by Timothy P.L. Roberts, PhD, vice chair of Radiology Research at the Children's Hospital of Philadelphia (CHOP; Philadelphia, PA, USA) and researcher at CHOP's Center for Autism Research (Philadelphia, PA, USA). A team from the University of California, San Francisco (UCSF; USA) led by Elliott H. Sherr, MD, PhD, also took part. John E. Spiro of the Simons Foundation Autism Research Initiative (SFARI; New York, NY, USA) was a coauthor of the study, and the foundation provided grant support.

Timothy P.L. Roberts, PhD, vice chair of Radiology Research at CHOP and researcher at CHOP's Center for Autism Research, commented, "This study shows an important connection between gene differences and differences in neurophysiology. It may also help to bridge a largely unexplored gap between genetics and behavior."

Roberts expects future studies to investigate other genes also implicated in ASDs, and other psychiatric disorders, in order to find whether they also involve similar response delays.

The research may be a basis for future medical treatments for some forms of autism, and cognitive, and language disabilities.

Related Links:

The Children's Hospital of Philadelphia (CHOP) 
CHOP's Center for Autism Research
UCSF



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Glucose Meter
StatStrip®
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.